{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:20:26Z","timestamp":1780514426068,"version":"3.54.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13048-019-0545-x","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T02:02:48Z","timestamp":1564538568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effectiveness and safety of the PlasmaJet\u00ae Device in advanced stage ovarian carcinoma: a systematic review"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7074-6201","authenticated-orcid":false,"given":"Gatske M.","family":"Nieuwenhuyzen-de Boer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacoba","family":"van der Kooy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleen J.","family":"van Beekhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"key":"545_CR1","unstructured":"SEER Cancer Statistics, National Cancer Institute, \n                    https:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html"},{"issue":"5","key":"545_CR2","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20(5):1248\u201359.","journal-title":"J Clin Oncol"},{"issue":"6","key":"545_CR3","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A Du Bois","year":"2009","unstructured":"Du Bois A, Reuss A, Pujade-Lauraine E, et al. Role of surgical outcome as prognostic factor in advanced EpithelialOvarian Cancer. Cancer. 2009;115(6):1234\u201344.","journal-title":"Cancer."},{"issue":"4","key":"545_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s13304-013-0213-4","volume":"65","author":"SG Vitale","year":"2013","unstructured":"Vitale SG, Marilli I, Lodato M, et al. The role of cytoreductive surgery in advanced-stage ovarian cancer: a systematic review. Updat Surg. 2013;65(4):265\u201370.","journal-title":"Updat Surg"},{"issue":"1","key":"545_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/IGC.0000000000000849","volume":"27","author":"EJ Tanner","year":"2017","unstructured":"Tanner EJ, Dun E, Sonoda Y, Olawaiye AB, Chi DS. A comparison of thermal plasma energy versus argon beam coagulator induced intestinal injury following vaporizations in a porcine model. Int J Gynecol Cancer. 2017;27(1):177\u201382.","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"545_CR6","first-page":"1326","volume":"20","author":"Y Sonoda","year":"2010","unstructured":"Sonoda Y, Olvera N, Chi DS, Brown CL, Abu-Rustum NR, Levine DA. Pathologic analysis of ex vivo plasma energy tumour destruction in patients with ovarian or peritoneal cancer. Int J Gynecol Cancer. 2010;20(8):1326\u201330.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"545_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ygyno.2016.10.030","volume":"144","author":"G Cordeiro Vidal","year":"2017","unstructured":"Cordeiro Vidal G, Babin G, Querleu D, Guyon F. Primary debulking surgery of the upper abdomen and the diaphragm, with a plasma device surgery system, for advanced ovarian cancer. Gynecol Oncol. 2017 Jan;144(1):223\u20134.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"545_CR8","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1097\/IGC.0000000000000788","volume":"26","author":"E Panuccio","year":"2016","unstructured":"Panuccio E, Leunen K, Van Nieuwenhuysen E, Neven P, Lambrechts S, Vergote I. Use of PlasmaJet for peritoneal Carcinomatosis in ovarian Cancer. Int J Gynecol Cancer. 2016 Oct;26(8):1521\u20134.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"545_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1701-2163(15)31048-3","volume":"35","author":"MC Renaud","year":"2013","unstructured":"Renaud MC, Sebastianelli A. Optimal cytoreduction with neutral argon plasma energy in selected patients with ovarian and primitive peritoneal cancer. J Obstet Gynaecol Can. 2013;35(1):49\u201352.","journal-title":"J Obstet Gynaecol Can"},{"issue":"2","key":"545_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ygyno.2015.11.028","volume":"140","author":"J Seror","year":"2016","unstructured":"Seror J, Bats AS, Habchi H, Lecuru F. Optimal surgical cytoreduction of the upper abdomen and the diaphragm for advanced ovarian cancer using PlasmaJet energy. Gynecol Oncol. 2016 Feb;140(2):372\u20133.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"545_CR11","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ygyno.2014.09.007","volume":"135","author":"S Butler-Manuel","year":"2014","unstructured":"Butler-Manuel S, Lippiatt J, Madhuri TK. Interval debulking surgery following neo-adjuvant chemotherapy for stage IVB ovarian cancer using neutral argon plasma (PlasmaJet (TM)). Gynecol Oncol. 2014;135(3):622\u20133.","journal-title":"Gynecol Oncol"},{"issue":"10","key":"545_CR12","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1007\/s11695-009-0067-5","volume":"20","author":"A Iannelli","year":"2010","unstructured":"Iannelli A, Schneck AS, Gugenheim J. Use of the PlasmaJet system in patients undergoing abdominal lipectomy following massive weight loss: a randomized controlled trial. Obes Surg. 2010 Oct;20(10):1442\u20137.","journal-title":"Obes Surg"},{"key":"545_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/S12885-019-5275-3","volume":"19","author":"GM Nieuwenhuyzen-de Boer","year":"2019","unstructured":"Nieuwenhuyzen-de Boer GM, Hofhuis W, Reesink-Peters N, Ewing-Graham PC, van BHJ, et al. Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOv-study): study protocol of a randomized controlled trial in the Netherlands. BMC Cancer. 2019;19:58. \n                    https:\/\/doi.org\/10.1186\/S12885-019-5275-3\n                    \n                  .","journal-title":"BMC Cancer"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-019-0545-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-019-0545-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-019-0545-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T23:26:28Z","timestamp":1596065188000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-019-0545-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["545"],"URL":"https:\/\/doi.org\/10.1186\/s13048-019-0545-x","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,31]]},"assertion":[{"value":"24 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For this review not applicable.The PlaComOv-study will be carried out according to the standards outlined in the Declaration of Helsinki. Ethics committee approval has been granted. All procedures involving patients have been approved by the Medical Ethical Committee of Erasmus Medical Centre Rotterdam in the Netherlands (trial protocol version 3.0 d.d. 20th November 2017, NL62035.078.17).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GN, JK and HB declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}